Nuvation Bio Inc.
NUVBUnited States
25 filed reports · 378 financial concepts · 1 earnings calls · 0 media appearances
Filed reports
25 reports · Jun 2020 to Jun 2026Each report counts once it has at least one extracted financial fact.
| Report type | Reports | Facts | Periods |
|---|---|---|---|
| Quarterly · 10-QSEC EDGAR | 19 | 2,619 | Jun 2020 to Jun 2026 |
| Annual · 10-KSEC EDGAR | 5 | 1,897 | Dec 2021 to Dec 2025 |
| Annual · 10-K/ASEC EDGAR | 1 | 61 | Dec 2020 |
Documents
| Period | Type | Period end | Published | Facts | Source |
|---|---|---|---|---|---|
| FY2026 Q2 | 10-Q | Jun 30, 2026 | Aug 6, 2026 | 360 | Open |
| FY2026 Q1 | 10-Q | Mar 31, 2026 | May 4, 2026 | 221 | Open |
| FY2025 | 10-K | Dec 31, 2025 | Mar 2, 2026 | 644 | Open |
| FY2025 Q3 | 10-Q | Sep 30, 2025 | Nov 3, 2025 | 272 | Open |
| FY2025 Q2 | 10-Q | Jun 30, 2025 | Aug 7, 2025 | 157 | Open |
| FY2025 Q1 | 10-Q | Mar 31, 2025 | May 7, 2025 | 140 | Open |
| FY2024 | 10-K | Dec 31, 2024 | Mar 6, 2025 | 361 | Open |
| FY2024 Q3 | 10-Q | Sep 30, 2024 | Nov 6, 2024 | 153 | Open |
| FY2024 Q2 | 10-Q | Jun 30, 2024 | Aug 5, 2024 | 126 | Open |
| FY2024 Q1 | 10-Q | Mar 31, 2024 | May 14, 2024 | 120 | Open |
| FY2023 | 10-K | Dec 31, 2023 | Feb 29, 2024 | 293 | Open |
| FY2023 Q3 | 10-Q | Sep 30, 2023 | Nov 2, 2023 | 137 | Open |
Financial data
378 concepts · 4,577 factsEach concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.
Financial370 concepts · 4,464 facts · Dec 2019 to Aug 2026
- Warrant liability40 · Dec 2020 to Jun 2026
- Accumulated other comprehensive income loss net of tax32 · Mar 2020 to Jun 2026
- Adjustments to additional paid in capital sharebased compensation requisite service period recognition value32 · Mar 2020 to Jun 2026
- Allocated share based compensation expense32 · Mar 2020 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents32 · Mar 2020 to Jun 2026
- Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect32 · Mar 2020 to Jun 2026
- Comprehensive income net of tax32 · Mar 2020 to Jun 2026
- Depreciation and amortization32 · Mar 2020 to Jun 2026
- Increase decrease in accounts payable32 · Mar 2020 to Jun 2026
- Increase decrease in accrued liabilities32 · Mar 2020 to Jun 2026
- Increase decrease in interest and dividends receivable32 · Mar 2020 to Jun 2026
- Interest income other32 · Mar 2020 to Jun 2026
- Marketable securities unrealized gain loss32 · Mar 2020 to Jun 2026
- Net cash provided by used in investing activities32 · Mar 2020 to Jun 2026
- Net cash provided by used in operating activities32 · Mar 2020 to Jun 2026
- Net income loss32 · Mar 2020 to Jun 2026
- Nonoperating income expense32 · Mar 2020 to Jun 2026
- Operating expenses (US GAAP)32 · Mar 2020 to Jun 2026
- Operating income loss32 · Mar 2020 to Jun 2026
- Other comprehensive income loss net of tax32 · Mar 2020 to Jun 2026
- Payments to acquire machinery and equipment32 · Mar 2020 to Jun 2026
- Payments to acquire marketable securities32 · Mar 2020 to Jun 2026
- Proceeds from sale and maturity of marketable securities32 · Mar 2020 to Jun 2026
- Professional fees32 · Mar 2020 to Jun 2026
Geography4 concepts · 71 facts · Dec 2021 to Jun 2026
- Revenue33 · Jun 2024 to Jun 2026
- New York City24 · Dec 2021 to Mar 2026
- Revenue (including assessed tax)11 · Sep 2024 to Dec 2025
- Revenue from contract with customer including assessed tax3 · Sep 2025
Product4 concepts · 42 facts · Jun 2024 to Jun 2026
- Revenue36 · Jun 2024 to Jun 2026
- Contract with customer liability revenue recognized3 · Dec 2025 to Jun 2026
- License2 · Dec 2024 to Mar 2025
- Research and development expense1 · Dec 2024
Segments
113 factsFigures broken down by business line, region, product or another axis the company reports on.
Statement geographical10 members · 71 facts
- CN12 · Jun 2024 to Jun 2026
- JP12 · Jun 2024 to Jun 2026
- US11 · Sep 2024 to Jun 2026
- New York City10 · Dec 2021 to Mar 2026
- San Francisco10 · Dec 2021 to Mar 2026
- Cn5 · Sep 2024 to Dec 2025
- Jp5 · Sep 2024 to Dec 2025
- MA4 · Dec 2024 to Mar 2026
- China And Japan1 · Jun 2024
- Us1 · Jun 2025
Product or service6 members · 42 facts
- License13 · Jun 2024 to Jun 2026
- Product11 · Jun 2024 to Jun 2026
- Research And Development Service Revenue9 · Jun 2024 to Jun 2026
- Product Revenue7 · Mar 2025 to Jun 2026
- License Revenue1 · Dec 2024
- Royalty Revenue1 · Mar 2025
Text from filings
Management commentary and risk factors, extracted from SEC filings only.
No commentary or risk-factor text for this company.
Earnings calls
1 calls · Aug 2026Transcripts with management claims and analyst questions, one per fiscal period.
- FY2026 Q2Aug 6, 2026
Executive media
Podcasts, interviews and conference appearances by the company's executives, with their claims.
No media appearances for this company.
Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Oct 16, 2026) and refreshed every few hours.